Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Bivalent COVID Shots May Hold Up Better Against Severe Omicron | MedPage Today
Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine
CDC reports on bivalent COVID-19 vaccine, Paxlovid effectiveness | AHA News
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Updated boosters add limited protection against Covid-19 illness, first real-world study shows | CNN
Eric Topol on X: "The BA.5 bivalent booster's effectiveness: by April 2023, "individuals previously vaccinated only with wild-type vaccines had little protection against Covid-19 hospital admission" restored by the booster (24K cases,
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
New Omicron-specific vaccines offer similar protection to existing boosters
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
New Omicron-specific vaccines offer similar protection to existing boosters
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Pfizer or Moderna - which is more effective as a COVID-19 booster shot? Findings from an MOH study - YouTube
